94 related articles for article (PubMed ID: 27065457)
1. The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs.
Lorenzato A; Torchiaro E; Olivero M; Di Renzo MF
Eur J Cancer; 2016 Jun; 60():59-68. PubMed ID: 27065457
[TBL] [Abstract][Full Text] [Related]
2. Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin.
Olivero M; Ruggiero T; Saviozzi S; Rasola A; Coltella N; Crispi S; Di Cunto F; Calogero R; Di Renzo MF
Mol Cancer Ther; 2006 May; 5(5):1126-35. PubMed ID: 16731744
[TBL] [Abstract][Full Text] [Related]
3. ILKAP regulates ILK signaling and inhibits anchorage-independent growth.
Kumar AS; Naruszewicz I; Wang P; Leung-Hagesteijn C; Hannigan GE
Oncogene; 2004 Apr; 23(19):3454-61. PubMed ID: 14990992
[TBL] [Abstract][Full Text] [Related]
4. p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis.
Coltella N; Rasola A; Nano E; Bardella C; Fassetta M; Filigheddu N; Graziani A; Comoglio PM; Di Renzo MF
Int J Cancer; 2006 Jun; 118(12):2981-90. PubMed ID: 16395709
[TBL] [Abstract][Full Text] [Related]
5. PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.
Musiani D; Hammond DE; Cirillo L; Erriquez J; Olivero M; Clague MJ; Di Renzo MF
J Proteome Res; 2014 Nov; 13(11):4970-82. PubMed ID: 25099161
[TBL] [Abstract][Full Text] [Related]
6. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
Pavan S; Olivero M; Corà D; Di Renzo MF
Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
[TBL] [Abstract][Full Text] [Related]
7. Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1.
Leung-Hagesteijn C; Mahendra A; Naruszewicz I; Hannigan GE
EMBO J; 2001 May; 20(9):2160-70. PubMed ID: 11331582
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo.
Bardella C; Dettori D; Olivero M; Coltella N; Mazzone M; Di Renzo MF
Clin Cancer Res; 2007 Apr; 13(7):2191-8. PubMed ID: 17404103
[TBL] [Abstract][Full Text] [Related]
9. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
10. Silencing of the integrin-linked kinase gene induces the apoptosis in ovarian carcinoma.
Liu Q; Xiao L; Yuan D; Shi X; Li P
J Recept Signal Transduct Res; 2012 Apr; 32(2):120-7. PubMed ID: 22384810
[TBL] [Abstract][Full Text] [Related]
11. ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.
Hausmann C; Temme A; Cordes N; Eke I
Oncotarget; 2015 Oct; 6(33):34592-605. PubMed ID: 26460618
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
[TBL] [Abstract][Full Text] [Related]
13. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
14. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
[TBL] [Abstract][Full Text] [Related]
16. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
[TBL] [Abstract][Full Text] [Related]
17. HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
Pavan S; Musiani D; Torchiaro E; Migliardi G; Gai M; Di Cunto F; Erriquez J; Olivero M; Di Renzo MF
Int J Cancer; 2014 Mar; 134(6):1289-99. PubMed ID: 23996744
[TBL] [Abstract][Full Text] [Related]
18. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
[TBL] [Abstract][Full Text] [Related]
19. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA
J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840
[TBL] [Abstract][Full Text] [Related]
20. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells.
Cruet-Hennequart S; Maubant S; Luis J; Gauduchon P; Staedel C; Dedhar S
Oncogene; 2003 Mar; 22(11):1688-702. PubMed ID: 12642872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
